Futrue
FUTRUE is a healthcare group founded in 2008, dedicated to revolutionizing healthcare by developing transformative medicines and technologies with agile, highly specialized teams. They focus on accelerating drug development, reducing development times, and fostering a culture of innovation, persistence, transparency, and integrity. Their mission is to improve patient lives and challenge conventional thinking in the pharmaceutical industry.
Industries
Nr. of Employees
medium (51-250)
Futrue
Am Haag 14, 82166 Gräfelfing, Germany
Products
Investigational analgesic therapeutic (development-stage)
A novel investigational medicine developed for the treatment of chronic pain that has progressed through preclinical and clinical development toward regulatory approval.
Medical probiotic product for gastrointestinal indications
A probiotic-based medicinal product developed for the treatment of irritable bowel syndrome and related conditions.
Artificial microbiome therapeutic (preclinical/clinical translation)
Laboratory-developed artificial microbiome intended for use as a therapeutic intervention in serious diseases, with plans for clinical testing.
Investigational analgesic therapeutic (development-stage)
A novel investigational medicine developed for the treatment of chronic pain that has progressed through preclinical and clinical development toward regulatory approval.
Medical probiotic product for gastrointestinal indications
A probiotic-based medicinal product developed for the treatment of irritable bowel syndrome and related conditions.
Artificial microbiome therapeutic (preclinical/clinical translation)
Laboratory-developed artificial microbiome intended for use as a therapeutic intervention in serious diseases, with plans for clinical testing.
Services
Outsourced clinical study design and execution aimed at reducing study duration and cost relative to standard industry practice.
Operation of a production site and engineering support to scale and optimize pharmaceutical manufacturing processes.
Regulatory strategy, submission support and quality assurance activities to support product certification and market authorization.
Performance-oriented media planning and execution across print, TV and digital channels, including e-detailing and DTC campaigns.
Management and scaling of online sales channels and digital commerce activities for OTC and consumer health products.
Identification and execution of M&A transactions, corporate development and strategic portfolio management support.
Outsourced clinical study design and execution aimed at reducing study duration and cost relative to standard industry practice.
Operation of a production site and engineering support to scale and optimize pharmaceutical manufacturing processes.
Regulatory strategy, submission support and quality assurance activities to support product certification and market authorization.
Performance-oriented media planning and execution across print, TV and digital channels, including e-detailing and DTC campaigns.
Management and scaling of online sales channels and digital commerce activities for OTC and consumer health products.
Identification and execution of M&A transactions, corporate development and strategic portfolio management support.
Expertise Areas
- Clinical trial management
- Therapeutic drug development (chronic pain and other indications)
- Microbiome and probiotic therapeutics
- Pharmaceutical manufacturing and process engineering
Key Technologies
- Microbiome engineering and translational microbiology
- Probiotic formulation and development
- Clinical data management and biostatistics
- Pharmaceutical process engineering
News & Updates
Vertanical's VER-01 Development Milestone
Vertanical achieved a breakthrough in pain medicine with the development of VER-01, a potential alternative to opioids, with approval expected as early as July.
Company Expansion and New Developments
FUTRUE continues to expand its portfolio with new companies in biotech, probiotics, research services, and digital marketing.
Over 90 pharmaceutical approvals
FUTRUE has achieved more than 90 approvals for its medicines.
Fastest growing companies in healthcare
Some of the companies within FUTRUE are among the fastest growing in the healthcare industry.
Innovative drug VER-01
Development of VER-01, a groundbreaking pain medication, within a team of fewer than 150 employees.
Vertanical's VER-01 Development Milestone
Vertanical achieved a breakthrough in pain medicine with the development of VER-01, a potential alternative to opioids, with approval expected as early as July.
Company Expansion and New Developments
FUTRUE continues to expand its portfolio with new companies in biotech, probiotics, research services, and digital marketing.
Over 90 pharmaceutical approvals
FUTRUE has achieved more than 90 approvals for its medicines.
Fastest growing companies in healthcare
Some of the companies within FUTRUE are among the fastest growing in the healthcare industry.
Innovative drug VER-01
Development of VER-01, a groundbreaking pain medication, within a team of fewer than 150 employees.